Processa Pharmaceuticals, Inc. Operating Expenses
Processa Pharmaceuticals, Inc. (PCSA) reported Operating Expenses of $2.96 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-11-12
- Processa Pharmaceuticals, Inc. operating expenses for the quarter ending 2020-09-30 was $2.96M, a 194.37% increase year-over-year.
- Processa Pharmaceuticals, Inc. operating expenses for the quarter ending 2020-06-30 was $801.99K, a 29.46% decline year-over-year.
- Processa Pharmaceuticals, Inc. operating expenses for the quarter ending 2019-09-30 was $1.00M, a 5.55% decline year-over-year.
- Processa Pharmaceuticals, Inc. operating expenses for the quarter ending 2019-06-30 was $1.14M, a 20.39% decline year-over-year.
- Processa Pharmaceuticals, Inc. operating expenses for fiscal 2017 was $1.80M, a 6.20% decline from fiscal 2016.
- Processa Pharmaceuticals, Inc. operating expenses for fiscal 2016 was $1.92M, a 28.26% decline from fiscal 2015.
- Processa Pharmaceuticals, Inc. operating expenses for fiscal 2015 was $2.68M, a 21.47% decline from fiscal 2014.
- Processa Pharmaceuticals, Inc. operating expenses for fiscal 2014 was $3.41M, a 10.53% increase from fiscal 2013.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 27 month | Operating Expenses 30 month | Operating Expenses 33 month | Operating Expenses 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | $2.96M 10-Q · filed 2020-11-12 | $3.76M derived: sum of 2 quarters · filed 2020-11-12 | $4.74M 10-Q · filed 2020-11-12 | |||||||||
| 2020-06-30 | $801.99K 10-Q · filed 2020-08-05 | $1.79M 10-Q · filed 2020-08-05 | ||||||||||
| 2019-09-30 | $1.00M 10-Q · filed 2020-11-12 | $2.14M derived: sum of 2 quarters · filed 2020-11-12 | $3.02M 10-Q · filed 2020-11-12 | |||||||||
| 2019-06-30 | $1.14M 10-Q · filed 2020-08-05 | $2.02M 10-Q · filed 2020-08-05 | ||||||||||
| 2018-09-30 | $1.06M 10-Q · filed 2019-11-14 | $2.49M derived: sum of 2 quarters · filed 2019-11-14 | $3.78M 10-Q · filed 2019-11-14 | $4.36M derived: sum of 4 quarters · filed 2019-11-14 | ||||||||
| 2018-06-30 | $1.43M 10-Q · filed 2019-08-14 | $2.72M 10-Q · filed 2019-08-14 | $3.30M derived: sum of 3 quarters · filed 2019-08-14 | $4.01M derived: sum of 4 quarters · filed 2019-08-14 | ||||||||
| 2018-03-31 | $1.29M 10-Q · filed 2018-05-21 | $1.87M derived: sum of 2 quarters · filed 2018-05-21 | $2.58M derived: sum of 3 quarters · filed 2018-11-14 | $2.86M derived: sum of 4 quarters · filed 2018-11-14 | ||||||||
| 2017-12-31 | $575.31K 10-K · filed 2018-04-16 | $1.29M derived: sum of 2 quarters · filed 2018-11-14 | $1.57M derived: sum of 3 quarters · filed 2018-11-14 | $1.80M 10-K · filed 2018-04-16 | ||||||||
| 2017-09-30 | $712.85K 10-Q · filed 2018-11-14 | $163.77K 10-Q · filed 2017-11-20 | $993.18K derived: sum of 2 quarters · filed 2018-11-14 | $1.23M 10-Q · filed 2018-11-14 | $187.81K 10-Q · filed 2017-11-20 | $1.46M derived: sum of 4 quarters · filed 2018-11-14 | ||||||
| 2017-06-30 | $280.33K 10-Q · filed 2018-08-14 | $10.35K 10-Q · filed 2017-10-04 | $503.92K 10-Q · filed 2018-08-14 | $24.04K 10-Q · filed 2017-10-04 | $750.49K derived: sum of 3 quarters · filed 2018-08-14 | $1.58M derived: sum of 4 quarters · filed 2018-08-14 | ||||||
| 2017-03-31 | $233.94K 10-Q · filed 2018-05-21 | $13.68K 10-Q · filed 2017-10-04 | $470.16K derived: sum of 2 quarters · filed 2018-05-21 | $1.30M derived: sum of 3 quarters · filed 2018-05-21 | $1.87M derived: sum of 4 quarters · filed 2018-05-21 | |||||||
| 2016-12-31 | $236.22K 10-K · filed 2018-04-16 | $1.07M derived: sum of 2 quarters · filed 2018-04-16 | $1.64M derived: sum of 3 quarters · filed 2018-04-16 | $1.92M 10-K · filed 2018-04-16 | $76.53K 10-K · filed 2017-09-25 | |||||||
| 2016-09-30 | $829.06K 10-K · filed 2018-04-16 | $4.97K 10-Q · filed 2017-09-08 | $1.40M derived: sum of 2 quarters · filed 2018-04-16 | $94.47K 10-Q · filed 2017-11-20 | $1.86M derived: sum of 4 quarters · filed 2018-04-16 | |||||||
| 2016-06-30 | $575.28K 10-K · filed 2018-04-16 | $8.98K 10-Q · filed 2017-08-30 | $89.50K 10-Q · filed 2017-10-04 | $1.03M derived: sum of 3 quarters · filed 2018-04-16 | $1.17M derived: sum of 4 quarters · filed 2018-04-16 | |||||||
| 2016-03-31 | $280.96K 10-K · filed 2018-04-16 | $80.52K 10-Q · filed 2017-08-07 | $457.30K derived: sum of 2 quarters · filed 2018-04-16 | $597.72K derived: sum of 3 quarters · filed 2018-04-16 | $2.49M derived: sum of 4 quarters · filed 2018-04-16 | |||||||
| 2015-12-31 | $176.34K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $316.77K derived: sum of 2 quarters · filed 2017-09-25 | $2.21M derived: sum of 3 quarters · filed 2017-09-25 | $2.68M 10-K · filed 2017-09-25 | ||||||||
| 2015-09-30 | $140.43K 10-Q · filed 2017-09-08 | $206.01K 10-Q · filed 2015-12-01 | $2.03M derived: sum of 2 quarters · filed 2017-09-08 | $2.50M 10-Q · filed 2017-09-08 | $2.82M 10-Q · filed 2015-12-01 | $3.15M derived: sum of 4 quarters · filed 2017-09-08 | ||||||
| 2015-06-30 | $1.89M 10-Q · filed 2017-08-30 | $2.00M 10-Q · filed 2015-08-19 | $2.36M 10-Q · filed 2017-08-30 | $2.61M 10-Q · filed 2015-08-19 | $3.01M derived: sum of 3 quarters · filed 2017-08-30 | $3.70M derived: sum of 4 quarters · filed 2017-08-30 | ||||||
| 2015-03-31 | $471.18K 10-Q · filed 2017-08-07 | $616.34K 10-Q · filed 2015-05-15 | $1.12M derived: sum of 2 quarters · filed 2017-08-07 | $1.81M derived: sum of 3 quarters · filed 2017-08-07 | $2.59M derived: sum of 4 quarters · filed 2017-08-07 | |||||||
| 2014-12-31 | $645.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $1.33M derived: sum of 2 quarters · filed 2017-06-19 | $2.12M derived: sum of 3 quarters · filed 2017-06-19 | $3.41M 10-K · filed 2017-06-19 | $4.25M 10-K · filed 2015-04-14 | |||||||
| 2014-09-30 | $689.13K 10-Q · filed 2015-12-01 | $1.47M derived: sum of 2 quarters · filed 2015-12-01 | $2.77M 10-Q · filed 2015-12-01 | $3.59M derived: sum of 4 quarters · filed 2015-12-01 | ||||||||
| 2014-06-30 | $780.90K 10-Q · filed 2015-08-19 | $2.08M 10-Q · filed 2015-08-19 | $2.91M derived: sum of 3 quarters · filed 2015-08-19 | $3.62M derived: sum of 4 quarters · filed 2015-08-19 | ||||||||
| 2014-03-31 | $1.30M 10-Q · filed 2015-05-15 | $2.12M derived: sum of 2 quarters · filed 2015-05-15 | $2.84M derived: sum of 3 quarters · filed 2015-05-15 | $3.57M derived: sum of 4 quarters · filed 2015-05-15 | $7.50M 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | $828.75K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $1.55M derived: sum of 2 quarters · filed 2015-04-14 | $2.28M derived: sum of 3 quarters · filed 2015-04-14 | $3.09M 10-K · filed 2015-04-14 | $6.20M 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | $719.89K 10-Q · filed 2014-11-13 | $1.45M derived: sum of 2 quarters · filed 2014-11-13 | $2.26M 10-Q · filed 2014-11-13 | $3.02M derived: sum of 4 quarters · filed 2014-11-13 | $5.37M 10-Q · filed 2013-11-08 | |||||||
| 2013-06-30 | $728.97K 10-Q · filed 2014-08-19 | $1.54M 10-Q · filed 2014-08-19 | $2.30M derived: sum of 3 quarters · filed 2014-08-19 | $2.89M derived: sum of 4 quarters · filed 2014-08-19 | $4.65M 10-Q/A · filed 2013-09-06 | |||||||
| 2013-03-31 | $808.19K 10-Q · filed 2014-05-14 | $1.57M derived: sum of 2 quarters · filed 2014-05-14 | $2.16M derived: sum of 3 quarters · filed 2014-05-14 | $2.61M derived: sum of 4 quarters · filed 2014-05-14 | ||||||||
| 2012-12-31 | $765.90K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $1.35M derived: sum of 2 quarters · filed 2014-03-27 | $1.80M derived: sum of 3 quarters · filed 2014-03-27 | $2.33M 10-K · filed 2014-03-27 | ||||||||
| 2012-09-30 | $583.24K 10-Q · filed 2013-11-08 | $1.03M derived: sum of 2 quarters · filed 2013-11-08 | $1.57M 10-Q · filed 2013-11-08 | |||||||||
| 2012-06-30 | $448.36K 10-Q/A · filed 2013-09-06 | $982.52K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |